Skip to main content
Top
Published in: Surgical Endoscopy 2/2018

01-02-2018

Increased glycine-amidated hyocholic acid correlates to improved early weight loss after sleeve gastrectomy

Authors: Tammy L. Kindel, Crystal Krause, Melissa C. Helm, Corrigan L. McBride, Dmitry Oleynikov, Rhishikesh Thakare, Jawaher Alamoudi, Vishal Kothari, Yazen Alnouti, Rohit Kohli

Published in: Surgical Endoscopy | Issue 2/2018

Login to get access

Abstract

Background

Bile acids (BAs) are post-prandial hormones that play an important role in glucose and lipid homeostasis as well as energy expenditure. Total and glycine-amidated BAs increase after sleeve gastrectomy (SG) and correlate to improved metabolic disease. No specific bile acid subtype has been shown conclusively to mediate the weight loss effect. Therefore, the objective of this study was to prospectively evaluate the comprehensive changes in meal-stimulated BAs after SG and determine if a specific change in the BA profile correlates to the early weight loss response.

Methods

Patients were prospectively enrolled at the University of Nebraska Medical Center who were undergoing a SG for treatment of morbid obesity. Primary and secondary plasma bile acids and their amidated (glycine, G-, or taurine, T-) subtypes were measured at fasting, 30 and 60 min after a liquid meal performed pre-op, and at 6 and 12 weeks post-op. Area under the curve (AUC) was calculated for the hour meal test for each bile acid subtype. BAs that were significantly increased post-op were correlated to body mass index (BMI) loss.

Results

Total BA AUC was significantly increased at 6 (p < 0.01) and 12 weeks post-op (p < 0.01) compared to pre-operative values. The increase in total BA AUC was due to a statistically significant increase in G-BAs. Nine different BA AUC subtypes were significantly increased at both 6 and 12 weeks post-op. Increased total and G-chenodeoxycholic acid AUC was significantly correlated to the 6 week BMI loss (p = 0.03). Increased G-hyocholic acid was significantly correlated to increased weight loss at both 6 (p = 0.05) and 12 weeks (p = 0.006).

Conclusions

SG induced an early and persistent post-prandial surge in multiple bile acid subtypes. Increased G-hyocholic consistently correlated with greater early BMI loss. This study provides evidence for a role of BAs in the surgical weight loss response after SG.
Literature
1.
go back to reference Peterli R, Wolnerhanssen BK, Vetter D, Nett P, Gass M, Borbely Y, Peters T, Schiesser M, Schultes B, Beglinger C, Drewe J, Bueter M (2017) Laparoscopic sleeve gastrectomy versus Roux-Y-gastric bypass for morbid obesity-3-year outcomes of the prospective randomized Swiss Multicenter Bypass or Sleeve Study (SM-BOSS). Ann Surg 265:466–473CrossRefPubMed Peterli R, Wolnerhanssen BK, Vetter D, Nett P, Gass M, Borbely Y, Peters T, Schiesser M, Schultes B, Beglinger C, Drewe J, Bueter M (2017) Laparoscopic sleeve gastrectomy versus Roux-Y-gastric bypass for morbid obesity-3-year outcomes of the prospective randomized Swiss Multicenter Bypass or Sleeve Study (SM-BOSS). Ann Surg 265:466–473CrossRefPubMed
2.
go back to reference Evers SS, Sandoval DA, Seeley RJ (2017) The physiology and molecular underpinnings of the effects of bariatric surgery on obesity and diabetes. Annu Rev Physiol 79:313–334CrossRefPubMed Evers SS, Sandoval DA, Seeley RJ (2017) The physiology and molecular underpinnings of the effects of bariatric surgery on obesity and diabetes. Annu Rev Physiol 79:313–334CrossRefPubMed
3.
go back to reference Fouladi F, Mitchell JE, Wonderlich JA, Steffen KJ (2016) The contributing role of bile acids to metabolic improvements after obesity and metabolic surgery. Obes Surg 26:2492–2502CrossRefPubMed Fouladi F, Mitchell JE, Wonderlich JA, Steffen KJ (2016) The contributing role of bile acids to metabolic improvements after obesity and metabolic surgery. Obes Surg 26:2492–2502CrossRefPubMed
4.
go back to reference Escalona A, Munoz R, Irribarra V, Solari S, Allende F, Francisco Miquel J (2016) Bile acids synthesis decreases after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis 12:763–769CrossRefPubMed Escalona A, Munoz R, Irribarra V, Solari S, Allende F, Francisco Miquel J (2016) Bile acids synthesis decreases after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis 12:763–769CrossRefPubMed
6.
go back to reference Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B (1999) Identification of a nuclear receptor for bile acids. Science 284:1362–1365CrossRefPubMed Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B (1999) Identification of a nuclear receptor for bile acids. Science 284:1362–1365CrossRefPubMed
8.
go back to reference Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, Messaddeq N, Harney JW, Ezaki O, Kodama T, Schoonjans K, Bianco AC, Auwerx J (2006) Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439(7075):484–489CrossRefPubMed Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, Messaddeq N, Harney JW, Ezaki O, Kodama T, Schoonjans K, Bianco AC, Auwerx J (2006) Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439(7075):484–489CrossRefPubMed
9.
go back to reference Kumar DP, Rajagopal S, Mahavadi S, Mirshahi F, Grider JR, Murthy KS, Sanyal AJ (2012) Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic β cells. Biochem Biophys Res Commun 427:600–605CrossRefPubMedPubMedCentral Kumar DP, Rajagopal S, Mahavadi S, Mirshahi F, Grider JR, Murthy KS, Sanyal AJ (2012) Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic β cells. Biochem Biophys Res Commun 427:600–605CrossRefPubMedPubMedCentral
10.
go back to reference Trabelsi MS, Daoudi M, Prawitt J, Ducastel S, Touche V, Sayin SI, Perino A, Brighton CA, Sebti Y, Kluza J, Briand O, Dehondt H, Vallez E, Dorchies E, Baud G, Spinelli V, Hennuyer N, Caron S, Bantubungi K, Caiazzo R, Reimann F, Marchetti P, Lefebvre P, Bäckhed F, Gribble FM, Schoonjans K, Pattou F, Tailleux A, Staels B, Lestavel S (2015) Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. Nat Commun 6:7629CrossRefPubMedPubMedCentral Trabelsi MS, Daoudi M, Prawitt J, Ducastel S, Touche V, Sayin SI, Perino A, Brighton CA, Sebti Y, Kluza J, Briand O, Dehondt H, Vallez E, Dorchies E, Baud G, Spinelli V, Hennuyer N, Caron S, Bantubungi K, Caiazzo R, Reimann F, Marchetti P, Lefebvre P, Bäckhed F, Gribble FM, Schoonjans K, Pattou F, Tailleux A, Staels B, Lestavel S (2015) Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. Nat Commun 6:7629CrossRefPubMedPubMedCentral
11.
go back to reference Kohli R, Bradley D, Setchell KD, Eagon JC, Abumrad N, Klein S (2013) Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids. J Clin Endocrinol Metab 98:E708–E712CrossRefPubMedPubMedCentral Kohli R, Bradley D, Setchell KD, Eagon JC, Abumrad N, Klein S (2013) Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids. J Clin Endocrinol Metab 98:E708–E712CrossRefPubMedPubMedCentral
12.
go back to reference De Giorgi S, Campos V, Egli L, Toepel U, Carrel G, Cariou B, Rainteau D, Schneiter P, Tappy L, Giusti V (2015) Long-term effects of Roux-en-Y gastric bypass on postprandial plasma lipid and bile acid kinetics in female non diabetic subjects: a cross-sectional pilot study. Clin Nutr 34:911–917CrossRefPubMed De Giorgi S, Campos V, Egli L, Toepel U, Carrel G, Cariou B, Rainteau D, Schneiter P, Tappy L, Giusti V (2015) Long-term effects of Roux-en-Y gastric bypass on postprandial plasma lipid and bile acid kinetics in female non diabetic subjects: a cross-sectional pilot study. Clin Nutr 34:911–917CrossRefPubMed
13.
go back to reference Werling M, Vincent RP, Cross GF, Marschall HU, Fandriks L, Lonroth H, Taylor DR, Alaghband-Zadeh J, Olbers T, Le Roux CW (2013) Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery. Scand J Gastroenterol 48:1257–1264CrossRefPubMed Werling M, Vincent RP, Cross GF, Marschall HU, Fandriks L, Lonroth H, Taylor DR, Alaghband-Zadeh J, Olbers T, Le Roux CW (2013) Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery. Scand J Gastroenterol 48:1257–1264CrossRefPubMed
14.
go back to reference Jahansouz C, Xu H, Hertzel AV, Serrot FJ, Kvalheim N, Cole A, Abraham A, Luthra G, Ewing K, Leslie DB, Bernlohr DA, Ikramuddin S (2016) Bile acids increase independently from hypocaloric restriction after bariatric surgery. Ann Surg 264:1022–1028CrossRefPubMed Jahansouz C, Xu H, Hertzel AV, Serrot FJ, Kvalheim N, Cole A, Abraham A, Luthra G, Ewing K, Leslie DB, Bernlohr DA, Ikramuddin S (2016) Bile acids increase independently from hypocaloric restriction after bariatric surgery. Ann Surg 264:1022–1028CrossRefPubMed
15.
go back to reference Belgaumkar AP, Vincent RP, Carswell KA, Hughes RD, Alaghband-Zadeh J, Mitry RR, le Roux CW, Patel AG (2016) Changes in bile acid profile after laparoscopic sleeve gastrectomy are associated with improvements in metabolic profile and fatty liver disease. Obes Surg 26:1195–1202CrossRefPubMed Belgaumkar AP, Vincent RP, Carswell KA, Hughes RD, Alaghband-Zadeh J, Mitry RR, le Roux CW, Patel AG (2016) Changes in bile acid profile after laparoscopic sleeve gastrectomy are associated with improvements in metabolic profile and fatty liver disease. Obes Surg 26:1195–1202CrossRefPubMed
16.
go back to reference Steinert RE, Peterli R, Keller S, Meyer-Gerspach AC, Drewe J, Peters T, Beglinger C (2013) Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial. Obesity 21:E660–E668CrossRefPubMed Steinert RE, Peterli R, Keller S, Meyer-Gerspach AC, Drewe J, Peters T, Beglinger C (2013) Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial. Obesity 21:E660–E668CrossRefPubMed
17.
go back to reference Khan FH, Shaw L, Zhang W, Salazar Gonzalez RM, Mowery S, Oehrle M, Zhao X, Jenkins T, Setchell KD, Inge TH, Kohli R (2016) Fibroblast growth factor 21 correlates with weight loss after vertical sleeve gastrectomy in adolescents. Obesity 24:2377–2383CrossRefPubMed Khan FH, Shaw L, Zhang W, Salazar Gonzalez RM, Mowery S, Oehrle M, Zhao X, Jenkins T, Setchell KD, Inge TH, Kohli R (2016) Fibroblast growth factor 21 correlates with weight loss after vertical sleeve gastrectomy in adolescents. Obesity 24:2377–2383CrossRefPubMed
18.
go back to reference Myronovych A, Kirby M, Ryan KK, Zhang W, Jha P, Setchell KD, Dexheimer PJ, Aronow B, Seeley RJ, Kohli R (2014) Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight-loss-independent manner. Obesity 22:390–400CrossRefPubMed Myronovych A, Kirby M, Ryan KK, Zhang W, Jha P, Setchell KD, Dexheimer PJ, Aronow B, Seeley RJ, Kohli R (2014) Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight-loss-independent manner. Obesity 22:390–400CrossRefPubMed
19.
go back to reference Ryan KK, Tremaroli V, Clemmensen C, Kovatcheva-Datchary P, Myronovych A, Karns R, Wilson-Perez HE, Sandoval DA, Kohli R, Backhed F, Seeley RJ (2014) FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 509:183–188CrossRefPubMedPubMedCentral Ryan KK, Tremaroli V, Clemmensen C, Kovatcheva-Datchary P, Myronovych A, Karns R, Wilson-Perez HE, Sandoval DA, Kohli R, Backhed F, Seeley RJ (2014) FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 509:183–188CrossRefPubMedPubMedCentral
20.
go back to reference Bathena SP, Mukherjee S, Olivera M, Alnouti Y (2013) The profile of bile acids and their sulfate metabolites in human urine and serum. J Chromatogr B 942–943:53–62CrossRef Bathena SP, Mukherjee S, Olivera M, Alnouti Y (2013) The profile of bile acids and their sulfate metabolites in human urine and serum. J Chromatogr B 942–943:53–62CrossRef
21.
go back to reference Huang J, Bathena SP, Cxanaky IL, Alnouti Y (2011) Simultaneous characterization of bile acids and their sulfate metabolites in mouse liver, plasma, bile and urine using LC-MS/MS. J Pharm Biomed Anal 55:1111–1119CrossRefPubMed Huang J, Bathena SP, Cxanaky IL, Alnouti Y (2011) Simultaneous characterization of bile acids and their sulfate metabolites in mouse liver, plasma, bile and urine using LC-MS/MS. J Pharm Biomed Anal 55:1111–1119CrossRefPubMed
22.
go back to reference Haluzikova D, Lacinova Z, Kavalkova P, Drapalova J, Krizova J, Bartlova M, Mraz M, Petr T, Vitek L, Kasalicky M, Haluzik M (2013) Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects. Obesity 21:1335–1342CrossRefPubMed Haluzikova D, Lacinova Z, Kavalkova P, Drapalova J, Krizova J, Bartlova M, Mraz M, Petr T, Vitek L, Kasalicky M, Haluzik M (2013) Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects. Obesity 21:1335–1342CrossRefPubMed
23.
go back to reference Khan FH, Kohli R (2016) Bariatric surgery: the rise and fall of bile acids. Surg Obes Relat Dis 12:770–771CrossRefPubMed Khan FH, Kohli R (2016) Bariatric surgery: the rise and fall of bile acids. Surg Obes Relat Dis 12:770–771CrossRefPubMed
24.
go back to reference Heuman DM (1989) Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res 30:719–730PubMed Heuman DM (1989) Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res 30:719–730PubMed
25.
go back to reference Radominska-Pyrek A, Zimniak P, Irshaid YM, Lester R, Tephly TR, St Pyrek J (1987) Glucuronidation of 6 alpa-hydroxy bile acids by human liver microsomes. J Clin Invest 80:234–241CrossRefPubMedPubMedCentral Radominska-Pyrek A, Zimniak P, Irshaid YM, Lester R, Tephly TR, St Pyrek J (1987) Glucuronidation of 6 alpa-hydroxy bile acids by human liver microsomes. J Clin Invest 80:234–241CrossRefPubMedPubMedCentral
26.
go back to reference Kuipers F, Bloks VW, Groen AK (2014) Beyond intestinal soap–bile acids in metabolic control. Nat Rev Endocrinol 10:488–498CrossRefPubMed Kuipers F, Bloks VW, Groen AK (2014) Beyond intestinal soap–bile acids in metabolic control. Nat Rev Endocrinol 10:488–498CrossRefPubMed
27.
go back to reference Bodin K, Lindbom U, Diczfalusy U (2005) Novel pathways of bile acid metabolism involving CYP3A4. Biochim Biophys Acta 1687:84–93CrossRefPubMed Bodin K, Lindbom U, Diczfalusy U (2005) Novel pathways of bile acid metabolism involving CYP3A4. Biochim Biophys Acta 1687:84–93CrossRefPubMed
28.
go back to reference Kano M, Matsumoto M, Kamano T, Tsurumaru M (1999) ELISA determination of serum hyocholic acid concentrations in humans and their possible clinical significance. Hepatogastroenterology 46:983–984PubMed Kano M, Matsumoto M, Kamano T, Tsurumaru M (1999) ELISA determination of serum hyocholic acid concentrations in humans and their possible clinical significance. Hepatogastroenterology 46:983–984PubMed
29.
go back to reference Chen J, Zhao KN, Chen C (2014) The role of CYP3A4 in the biotransformation of bile acids and therapeutic implication for cholestasis. Ann Transl Med 2:7PubMedPubMedCentral Chen J, Zhao KN, Chen C (2014) The role of CYP3A4 in the biotransformation of bile acids and therapeutic implication for cholestasis. Ann Transl Med 2:7PubMedPubMedCentral
30.
go back to reference Stedman C, Robertson G, Coulter S, Liddle C (2004) Feed-forward regulation of bile acid detoxification by CYP3A4: studies in humanized transgenic mice. J Biol Chem 279:11336–11343CrossRefPubMed Stedman C, Robertson G, Coulter S, Liddle C (2004) Feed-forward regulation of bile acid detoxification by CYP3A4: studies in humanized transgenic mice. J Biol Chem 279:11336–11343CrossRefPubMed
31.
go back to reference Araki Y, Andoh A, Bamba H, Yoshikawa K, Doi H, Komai Y, Higuchi A, Fujiyama Y (2003) The cytotoxicity of hydrophobic bile acids is ameliorated by more hydrophilic bile acids in intestinal cell lines IEC-6 and Caco-2. Oncol Rep 10:1931–1936PubMed Araki Y, Andoh A, Bamba H, Yoshikawa K, Doi H, Komai Y, Higuchi A, Fujiyama Y (2003) The cytotoxicity of hydrophobic bile acids is ameliorated by more hydrophilic bile acids in intestinal cell lines IEC-6 and Caco-2. Oncol Rep 10:1931–1936PubMed
32.
go back to reference Sato H, Macchiarulo A, Thomas C, Gioiello A, Une M, Hofmann AF, Saladin R, Schoonjans K, Pellicciari R, Auwerx J (2008) Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies. J Med Chem 51:1831–1841CrossRefPubMed Sato H, Macchiarulo A, Thomas C, Gioiello A, Une M, Hofmann AF, Saladin R, Schoonjans K, Pellicciari R, Auwerx J (2008) Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies. J Med Chem 51:1831–1841CrossRefPubMed
33.
go back to reference Sayin SI, Wahlstrom A, Felin J, Jantti S, Marschall HU, Bamberg K, Angelin B, Hyotylainen T, Oresic M, Backhed F (2013) Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 17:225–235CrossRefPubMed Sayin SI, Wahlstrom A, Felin J, Jantti S, Marschall HU, Bamberg K, Angelin B, Hyotylainen T, Oresic M, Backhed F (2013) Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 17:225–235CrossRefPubMed
Metadata
Title
Increased glycine-amidated hyocholic acid correlates to improved early weight loss after sleeve gastrectomy
Authors
Tammy L. Kindel
Crystal Krause
Melissa C. Helm
Corrigan L. McBride
Dmitry Oleynikov
Rhishikesh Thakare
Jawaher Alamoudi
Vishal Kothari
Yazen Alnouti
Rohit Kohli
Publication date
01-02-2018
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 2/2018
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-017-5747-y

Other articles of this Issue 2/2018

Surgical Endoscopy 2/2018 Go to the issue